SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Granules India informs about board meeting

18 Dec 2025 Evaluate

Granules India has informed that a meeting of the Board of Directors of the Company is scheduled to be held on December 23, 2025, to consider and evaluate proposals for raising funds on a private placement basis by way of preferential issue including the determination of issue price, subject to such regulatory/ statutory approvals as may be required.

The above information is a part of company’s filings submitted to BSE.

Granules India Share Price

875.10 -28.05 (-3.11%)
17-Jul-2026 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1933.10
Dr. Reddys Labs. 1210.85
Cipla 1418.40
Lupin 2441.50
Zydus Lifesciences 1142.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: